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Purpose: To evaluate factors that can influence the prevalence of amblyopia in children with anisometropia.
Methods: We retrospectively reviewed the records of 63 children 2 to 13 years of age who had anisometropic am-
blyopia with a difference in the refractive errors between the eyes of at least two diopters (D). The type of aniso-
metropia (myopia, hyperopia, and astigmatism), degree of anisometropia (＜2-3 D, ＜3-4 D, or ＞4 D), best cor-
rected visual acuity (BCVA) of the amblyopic eye at the time of initial examination, BCVA differences between 
sound and amblyopic eyes, whether or not occlusion therapy was performed, compliance with occlusion therapy, 
and the patient’s age when eyeglasses were first worn were investigated.
Results: There was an increase in the risk of amblyopia with increased magnitude of anisometropia (p=0.021). The 
prevalence of amblyopia was higher in the BCVA ＜20/40 group and in patients with BCVA differences ＞4 lines 
between sound and amblyopic eyes (p=0.008 and p=0.045, respectively). There was no statistical relationship 
between the prevalence of amblyopia and the type of anisometropia or the age when eyeglasses were first worn. 
Poor compliance with occlusion therapy was less likely to achieve successful outcome (p=0.015).
Conclusions: Eyes with poor initial visual acuities of ＜20/40, a high magnitude of anisometropia, and a ＞4 line dif-
ference in the BCVA between sound and amblyopic eyes at the initial visit may require active treatment.
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Amblyopia is a disorder of the visual system that is charac-
terized by a decrease in the best corrected visual acuity 
(BCVA) in an eye with no organic pathology [1]. Anisometropia 
is a well-known cause of amblyopia [2]. Unequal refractive 
error between the two eyes produces abnormal binocular in-
teraction and/or visual deprivation. Patients with anisome-
tropic amblyopia usually have no identifiable ocular defects 
and the visual acuity of the sound eye is normal, which makes 
it difficult to diagnose the symptoms, and thus early treat-
ment is often delayed. Because improvement in visual acuity 
with amblyopia treatment depends on the age at which treat-
ment begins, earlier detection of children with anisometropic 
amblyopia is desired [3-6].
According to Weakley [7,8], there is an increased risk of 
amblyopia with myopic anisometropia ＞2 diopters (D), hy-
peropic anisometropia ＞1 D, and astigmatic anisometropia 
＞1.5 D. Hussein et al. [9], in a study of amblyopic children 
older than six years of age, found that the risk factors for ani-
sometropic amblyopia treatment failure were age ＞6 years 
at the onset of treatment, the presence of astigmatism of  ＞1.5 
D in the amblyopic eye, poor compliance with treatment, and 
initial visual acuity in the amblyopic eye of ≤20/200.
The aim of this study was to determine and analyze factors 
early in the course of treatment that influence the prevalence 
of amblyopia in children with anisometropia.
Materials and Methods
Between January 2000 and December 2007, we retro-
spectively reviewed the records of 63 children 2 to 13 years 
of age who had anisometropia with a difference in the re-
fractive power between the eyes of at least 2 D. Patients with 
at least six months of follow-up were included in the study. Korean J Ophthalmol Vol.24, No.4, 2010
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Table 1. Prevalence of amblyopia as a function of the 
type of anisometropia at the initial visit
Myopia Hypermetropia Astigmatism
No. of patients   18   23    22
Amblyopia (%)   13 (72.2)   12 (52.0)     8 (36.4)
Average 
anisometropia (D)
5.13±3.55 2.95±0.99 3.18±1.33
p=0.770 (Pearson’s chi-square test). 
D=diopters.
Table 2. Prevalence of amblyopia as a function of the 
magnitude of anisometropia
Group I
* Group II
† Group III
‡ Total
Amblyopia (%)  9 (39.1) 12 (52.2) 12 (70.6) 33 (52.4)
Non-amblyopia (%) 14 (60.9) 11 (47.8)  5 (29.4) 30 (47.6)
T o t a l 2 32 31 76 3
p=0.021 (Pearson’s chi-square test).
*≥2 diopters (D), ＜3 D; 
†≥3 D, ＜4 D; 
‡≥4 D (anisometropia 
magnitude).
Visual acuity was measured at a 4 m distance using an inter-
national standard vision chart (Jin’s vision chart), and am-
blyopia was defined as a BCVA difference between the 
sound and amblyopic eyes of more than two lines on the vi-
sion chart. Any patient with structural ocular abnormalities, 
including strabismus, history of spectacle correction, occlu-
sion or penalization therapy, previous ocular surgery, ocular 
trauma, or neurologic disorders which could influence visual 
acuity, or with BCVA of the sound eye ＜20/40 was excluded 
from the research. Each patient’s age at diagnosis, un-
corrected visual acuity and BCVA, and examination of the 
external eye and fundus were studied. Cycloplegic refraction 
was performed after application of 1% cyclopentolate eye 
drops. Eyeglasses were prescribed based on the results of cy-
cloplegic refraction. 
The prevalence of amblyopia at the final visit was ana-
lyzed by studying the type of anisometropia (myopia, hyper-
metropia, and astigmatism), magnitude of anisometropia, 
BCVA at the start of treatment (≥20/40 or ＜20/40), BCVA 
differences between the sound and amblyopic eyes (≥4 lines 
or ＜4 lines), and the age at which eyeglasses were first worn 
(＜5 years of age or ≥5 years of age). Anisometropia was 
divided into the following two groups: spherical anisometropia, 
in which the difference in the spherical equivalent between 
the eye was ＞2 D, while the cylinder power difference was 
＜2 D, and cylindrical anisometropia, which had a ＞2 D cy-
lindrical power difference. The magnitude of anisometropia 
was graded into an arbitrary three-category classification 
(Group 1, 2 to ＜3 D; Group 2, 3 to ＜4 D; Group 3, ≥4 D).
Full spherical and astigmatic refractive errors were cor-
rected in each patient, and, depending on the visual improve-
ment at the second visit (≥2 lines difference between sound 
and amblyopic eyes persisted), the patient was required to 
patch the sound eye for 4 to 6 hours per day. The compliance 
with patching treatment was divided into the following two 
groups based on the parents’ estimate: children with good 
compliance who followed the treatment guideline an esti-
mated ≥75% of the time, and poor compliance (＜75% of the 
time).
A chi-square test and t-test were conducted for statistical 
analysis using SPSS ver. 15.0 (SPSS Inc., Chicago, IL, USA), 
and a p＜0.05 was considered to be statistically significant. 
Results
The mean age at the start of treatment was 5.9±3.9 years. 
Thirty-three patients (52.3%) were male and 30 patients 
(47.7%) were female. The follow-up period averaged 57.2 
±38.0 months, with a maximum of 147 months. Forty-one 
patients were diagnosed with spherical anisometropia, 18 
were diagnosed with myopic spherical anisometropia, and 13 
(72.2%) patients had amblyopia. Twelve of 23 (52.1%) pa-
tients with hypermetropic spherical anisometropia also had 
amblyopia, and eight of 22 (36.4%) astigmatic anisometropia 
patients had amblyopia. There were no frequency differences 
according to the type of anisometropia (myopic spherical 
anisometropia, hyperopic spherical anisometropia, and astig-
matic anisometropia; p=0.770) (Table 1).
Nine (39.1%) of 23 patients in Group 1 (≥2 D, ＜3 D), 12 
(52.1%) of 23 patients in Group 2 (≥3 D, ＜4 D), and 12 
(70.6%) of 17 patients in Group 3 (≥4 D) had amblyopia. In 
general, children with higher magnitudes of anisometropia 
had a higher prevalence of amblyopia (p=0.021) (Table 2). 
Twenty-seven patients had an initial BCVA of ＜20/40, 17 
(63.0%) of which had amblyopia. Sixteen of 36 (44.4%) pa-
tients with BCVA ≥20/40 had amblyopia. There were differ-
ences among the statistical frequencies of amblyopia be-
tween the two groups (p=0.008), and an initial BCVA 
＜20/40 in the amblyopic eye was a risk factor for the devel-
opment of amblyopia. Among 18 patients ＜5 years of age at 
the initial visit, 12 had an initial BCVA of ＜20/40, and seven 
(58.3%) of these 12 patients had amblyopia. Of the six pa-
tients whose initial BCVA ≥20/40, one (16.7%) had 
amblyopia. Forty-five patients were ≥5 years of age at initial 
presentation. Fifteen patients had an initial BCVA of ＜20/40 
and ten (66.7%) of these patients had amblyopia. Fifteen of 
30 (50.0%) patients whose initial BCVA ≥20/40 had 
amblyopia. Given an initial BCVA ＜20/40, the risk of am-
blyopia at the final visit was not significantly different be-
tween the initial presentation groups with respect to age 
(p=0.656).
Eighteen patients were ＜5 years of age at the time of the 
initial spectacle correction and nine (50.0%) had amblyopia, 
while 24 (53.3%) of 45 patients ≥5 years of age had amblyopia. 
There was no statistical significance regarding the preva-
lence of amblyopia between patients ＜5 and ≥5 years of age 
at the time of initial spectacle correction (p=0.811).
Forty-six patients underwent patching therapy, and the 
mean duration of patching therapy was 22.2±17.9 months. CE Lee, et al. Factors Influencing Anisometropic Amblyopia
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Table 3. Comparison between patching therapy and non-patching therapy groups
Patching (+)
*
Patching (－)
*
Good compliance
† Poor compliance
† Total
Amblyopia (%) 10 (40.0) 13 (61.9) 23 (50.0) 10 (58.8)
Non-amblyopia (%) 15 (60.0)  8 (38.1) 23 (50.0) 11 (41.2)
*p=0.534 (Pearson’s chi-square test); 
†p=0.027 (Pearson’s chi-square test).
Table 4. Prevalence of amblyopia as a function of the BCVA differences between sound and amblyopic eyes
BCVA of amblyopic eye
Non-amblyopia
† Amblyopia
†
Initial Final
*
＜4 lines 0.68±0.13 0.86±0.15 9 (81.8%) 2 (18.2%)
≥4 lines 0.30±0.12 0.75±0.21 6 (42.9%) 8 (57.1%)
BCVA=best corrected visual acuity.
*After patching of the sound eye for 4 to 6 hours per day; 
†p=0.045 (Pearson’s chi-square test).
Twenty-three (50.0%) of 46 patients who were treated with 
patching therapy had amblyopia, and ten (58.8%) of 17 pa-
tients without patching treatment had amblyopia. Good com-
pliance with patching occurred in 25 patients, ten (40.0%) of 
whom had amblyopia. Of the 21 patients with poor com-
pliance, 13 (61.9%) had amblyopia. Poor compliance with 
patching was a risk factor for amblyopia (p=0.027), while no 
differences existed in patients who were or were not treated 
with patching therapy (p=0.534) (Table 3).
Among the patients with good compliance to patching 
therapy, 11 had ＜4 lines of difference in the BCVA between 
the sound and amblyopic eyes at the initial presentation, and 
two (18.2%) patients had amblyopia at the final visit. Eight 
(57.1%) of 14 patients who had ≥4 lines of difference in the 
BCVA between the eyes at the initial visit presented with am-
blyopia at the final visit. A difference in the BCVA between 
the sound and amblyopic eyes ≥4 lines was a risk factor for 
the development of amblyopia in patients with good com-
pliance to patching therapy (p=0.045) (Table 4).
Discussion
Amblyopia is one of the leading causes of acquired mo- 
nocular visual impairment [10], with an estimated prevalence 
in the pediatric population ranging from 4.7% to 7.5% [11]. 
Children with anisometropic amblyopia typically are diagnosed 
later than are children having other types of amblyopia, like-
ly reflecting the lack of noticeable physical abnormalities in 
these children, in contrast to children with strabismus, who 
usually have an obvious condition that is easily recognized 
[3-5]. With respect to the magnitudes of anisometropia, Leon 
et al. [12] demonstrated that children with higher magnitudes 
of anisometropia had a higher prevalence and greater depths 
of amblyopia. However, Hussein et al. [9] concluded that the 
type, amount of refractive error, and the difference in re-
fractive power between the eyes were significant risk factors 
for treatment failure. In the current study, children with high-
er magnitudes of anisometropia had a higher prevalence of 
amblyopia.
It is known that amblyopia is more severe and more fre-
quent in hypermetropic anisometropia than it is myopic ani-
sometropia [13]. In a study by Weakley [8], there was a ten-
dency for the development of amblyopia at lower levels of 
hyperopic anisometropia (spherical hypermetropic anisome-
tropia ＞1-2 D) compared to that with myopic anisometropia 
(spherical myopic anisometropia ＞-2 to -3 D). However, in 
patients with equal levels of spherical myopic anisometropia 
and spherical hypermetropic anisometropia ＞2 D, both the 
incidence and severity of amblyopia were remarkably 
similar.
 Kim et al. [14] reported that there is no significant 
difference in the frequencies of amblyopia between spherical 
and cylindrical anisometropia patients; however, in spherical 
anisometropia, hyperopic anisometropia patients have a 
higher risk for developing amblyopia. However, in this study, 
there were no differences in the frequency of amblyopia de-
velopment among patients having myopic spherical aniso-
metropia, hypermetropic spherical anisometropia, or astigmatic 
anisometropia. The lack of statistical significance for this 
comparison was probably due to the relatively higher mag-
nitude of anisometropia in the myopia anisometropia group 
than in the other groups, and the small numbers in each 
group of this study.
Several studies have suggested that that the factors influ-
encing outcomes of amblyopia are the initial age of treatment 
and the BCVA of the weaker eye at the time of the initial 
treatment. According to Kim et al. [15], in a study involving 
66 amblyopic children, the duration of treatment was longer 
in children with an initially poorer BCVA and in younger 
children compared to that in older children with better 
BCVAs at the time of diagnosis. Chen et al. [16] reported 
that, of 60 anisometropic amblyopic children with spectacle 
correction alone, the resolution of amblyopia was related to 
better initial visual acuity and lesser degrees of anisometropia. 
Hussein et al. [9] found that an initial visual acuity in the am-
blyopic eye of 20/200 or worse was a risk factor of treatment 
failure, and patients with very poor vision in the amblyopic 
eye can have significant improvement in vision, but may not 
achieve a final vision of 20/40 or better. In the current study, Korean J Ophthalmol Vol.24, No.4, 2010
228
the frequency of amblyopia development was higher in chil-
dren with an initial visual acuity ＜20/40 than it was in chil-
dren with an initial visual acuity of ≥20/40. This result sug-
gests that, under conditions of high dependence on the sound 
eye, abnormal binocular interaction and/or visual deprivation 
resulted.
Older children with amblyopia generally respond less fa-
vorably to treatment [1]. Hussein et al. [9]
 demonstrated that 
age greater than six years at the onset of treatment was a risk 
factor for failure to achieve functional success. According to 
Leon et al. [12], children age three and older had an increased 
risk of amblyopia compared with that of younger children for 
moderate (≥4, ＜6 line difference) levels of anisometropia. 
However, Woodruff et al. [4]
 could not find a correlation be-
tween unfavorable amblyopia treatment outcome and age at 
initiation of treatment. Rho et al. [17] also could not docu-
ment a statistical significance between age at initial treatment 
and treatment outcome. In the current study, there was no 
statistical significance of amblyopia prevalence in patients 
＜5 year of age at the time of initial spectacle correction. We 
also found that there was no significant difference of am-
blyopia risk between the ＜5 year of age group and ≥5 year of 
age group among patients with an initial BCVA ＜20/40. 
Such a discrepancy between studies indicates the need for 
more research to determine whether age at initial treatment 
affects treatment outcome.
Previous studies have demonstrated that poor patching 
compliance was associated with a poor outcome. Hussein et 
al. [9] demonstrated inadequate compliance with treatment 
according to parental report at the first follow-up examination 
was a key predictive factor for failure risk. Choi and Kim 
[18] have demonstrated a relationship between anisome-
tropic amblyopia and occlusion therapy when the treatment 
age was younger and the compliance rate was higher in the 
success group compared with those of the failure group.
 In 
the current study, patching therapy and the amblyopia prev-
alence had no significant relationship; however, poor com-
pliance with patching was a risk factor for the prevalence of 
amblyopia.
A difference in the BCVA between the eyes is related to 
treatment outcome in amblyopia. Lee et al. [19], in a study of 
80 patients with strabismic amblyopia and anisometropic 
amblyopia, demonstrated that patients with ≤4 lines of differ-
ence in the BCVA between the sound and amblyopic eyes at 
the initial visit had a high success rate with patching therapy. 
Although strabismic amblyopia was excluded from our 
study, we also found that BCVA differences between sound 
and amblyopic eyes of ≥4 lines was a risk factor for the devel-
opment of amblyopia in patients having undergone patching 
therapy.
Regarding the limitations of the current study, there was a 
relatively small number of patients and lacks of stand-
ardization in the age groups and treatment method. A large 
prospective study is thus required to establish more statisti-
cally powerful results.
In conclusion, eyes with an initial visual acuity of 
＜20/40, a high magnitude of anisometropia, and a ≥4 line 
difference in BCVA between the sound and amblyopic eyes 
were less likely to achieve successful outcomes. Therefore, 
such children must receive careful treatment. In addition, 
parents and guardians must be fully aware of the risk 
through sufficient explanation, regular observation, and 
amblyopia treatment.
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